Attenuation of Marek's disease virus by deletion of open reading frame RLORF4 but not RLORF5a

Journal of Virology

Volumn 79, Issue 18, 2005, Pages 11647-11659

  Jarosinski, Keith W ^a   Osterrieder, Nikolaus ^a   Nair, Venugopal K ^b   Schat, Karel A ^a  

^a Department of Obstetrics Gynecology   (United States)

^b INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AVIAN LYMPHOMATOSIS HERPETOVIRUS; BACTERIAL ARTIFICIAL CHROMOSOME; BIRD DISEASE; CARCINOGENESIS; CHICKEN; CONTROLLED STUDY; DELETION MUTANT; GENE DELETION; GENE FUNCTION; LYMPHOMA; MOLECULAR CLONING; NONHUMAN; OPEN READING FRAME; PLAQUE FORMING CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS ATTENUATION; VIRUS PATHOGENESIS; VIRUS PLAQUE; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; BASE SEQUENCE; CELLS, CULTURED; CHICKENS; CHROMOSOMES, ARTIFICIAL, BACTERIAL; DNA, VIRAL; MARDIVIRUS; MAREK DISEASE; OPEN READING FRAMES; PHENOTYPE; SEQUENCE DELETION; VIRUS REPLICATION;

AVES; BACTERIA (MICROORGANISMS); GALLID HERPESVIRUS 2; GALLUS GALLUS;

EID: 24644511581     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.18.11647-11659.2005     Document Type: Article

References (45)

1. Bradley, G., M. Hayashi, G. Lancz, A. Tanaka, and M. Nonoyama. 1989. Structure of the Marek's disease virus BamHI-H gene family: genes of putative importance for tumor induction. J. Virol. 63:2534-2542.
2. Bradley, G., G. Lancz, A. Tanaka, and M. Nonoyama. 1989. Loss of Marek's disease virus tumorigenicity is associated with truncation of RNAs transcribed within BamHI-H. J. Virol. 63:4129-4135.
3. Calnek, B. W. 2001. Pathogenesis of Marek's disease virus infection. Curr. Top. Microbiol. Immunol. 255:25-55.
4. Churchill, A. E., R. C. Chubb, and W. Baxendale. 1969. The attenuation, with loss of oncogenicity of the herpes-type virus of Marek's disease (strain HPRS-16) on passage in cell culture. J. Gen. Virol. 4:557-564.
5. Cortes, P. L., and C. J. Cardona. 2004. Pathogenesis of a Marek's disease virus mutant lacking vIL-8 in resistant and susceptible chickens. Avian Dis. 48:50-60.
6. Cui, X., L. F. Lee, W. M. Reed, H. J. Kung, and S. M. Reddy. 2004. Marek's disease virus-encoded vIL-8 gene is involved in early cytolytic infection but dispensable for establishment of latency. J. Virol. 78:4753-4760.
7. Datsenko, K. A., and B. L. Wanner. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. USA 97:6640-6645.
8. Fukuchi, K., A. Tanaka, L. W. Schierman, R. L. Witter, and M. Nonoyama. 1985. The structure of Marek disease virus DNA: the presence of unique expansion in nonpathogenic viral DNA. Proc. Natl. Acad. Sci. USA 82:751-754.
9. Jarosinski, K. W., B. L. Njaa, P. H. O'Connell, and K. A. Schat. 2005. Pro-inflammatory responses in chicken spleen and brain tissues after infection with very virulent plus Marek's disease virus. Viral Immunol. 18:148-161.
10. Jarosinski, K. W., P. H. O'Connell, and K. A. Schat. 2003. Impact of deletions within the BamHI-L fragment of attenuated Marek's disease virus on vIL-8 expression and the newly identified transcript of open reading frame LORF4. Virus Genes 26:255-269.
11. Jarosinski, K. W., R. Yunis, P. H. O'Connell, C. J. Markowski-Grimsrud, and K. A. Schat. 2002. Influence of genetic resistance of the chicken and virulence of Marek's disease virus (MDV) on nitric oxide responses after MDV infection. Avian Dis. 46:636-649.
12. Jones, D., L. Lee, J. L. Liu, H. J. Kung, and J. K. Tillotson. 1992. Marek disease virus encodes a basic-leucine zipper gene resembling the fos/jun oncogenes that is highly expressed in lymphoblastoid tumors. Proc. Natl. Acad. Sci. USA 89:4042-4046.
13. Kamil, J. P., B. K. Tischer, S. Trapp, V. K. Nair, N. Osterrieder, and H. J. Kung. 2005. vLIP, a viral lipase homologue, is a virulence factor of Marek's disease virus. J. Virol. 79:6984-6996.
14. Kopacek, J., L. J. Ross, V. Zelnik, and J. Pastorek. 1993. The 132 bp repeats are present in RNA transcripts from 1.8 kb gene family of Marek disease virus-transformed cells. Acta Virol. 37:191-195.
15. Lee, E. C., D. Yu, J. Martinez de Velasco, L. Tessarollo, D. A. Swing, D. L. Court, N. A. Jenkins, and N. G. Copeland. 2001. A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 73:56-65.
16. Levy, A. M., Y. Izumiya, P. Brunovskis, L. Xia, M. S. Parcells, S. M. Reddy, L. Lee, H. W. Chen, and H. J. Kung. 2003. Characterization of the chromosomal binding sites and dimerization partners of the viral oncoprotein Meq in Marek's disease virus-transformed T cells. J. Virol. 77:12841-12851.
17. Liu, J. L., S. F. Lin, L. Xia, P. Brunovskis, D. Li, I. Davidson, L. F. Lee, and H. J. Kung. 1999. MEQ and V-ILS: cellular genes in disguise? Acta Virol. 43:94-101.
18. Liu, J. L., Y. Ye, L. F. Lee, and H. J. Kung. 1998. Transforming potential of the herpesvirus oncoprotein MEQ: morphological transformation, serum-independent growth, and inhibition of apoptosis. J. Virol. 72:388-395.
19. Lupiani, B., L. F. Lee, X. Cui, I. Gimeno, A. Anderson, R. W. Morgan, R. F. Silva, R. L. Witter, H. J. Kung, and S. M. Reddy. 2004. Marek's disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication. Proc. Natl. Acad. Sci. USA 101:11815-11820.
20. Ohashi, K., W. Zhou, P. H. O'Connell, and K. A. Schat. 1994. Characterization of a Marek's disease virus BamHI-L-specific cDNA clone obtained from a Marek's disease lymphoblastoid cell line. J. Virol. 68:1191-1195.
21. Parcells, M. S., A. S. Anderson, and T. W. Morgan. 1995. Retention of oncogenicity by a Marek's disease virus mutant lacking six unique short region genes. J. Virol. 69:7888-7898.
22. Parcells, M. S., S. F. Lin, R. L. Dienglewicz, V. Majerciak, D. R. Robinson, H. C. Chen, Z. Wu, G. R. Dubyak, P. Brunovskis, H. D. Hunt, L. F. Lee, and H. J. Kung. 2001. Marek's disease virus (MDV) encodes an interleukin-8 homolog (vIL-8): characterization of the vIL-8 protein and a vIL-8 deletion mutant MDV. J. Virol. 75:5159-5173.
23. Peng, Q., M. Zeng, Z. A. Bhuiyan, E. Ubukata, A, Tanaka, M. Nonoyama, and Y. Shirazi. 1995. Isolation and characterization of Marek's disease virus (MDV) cDNAs mapping to the BamHI-I2, BamHI-Q2, and BamHI-L fragments of the MDV genome from lymphoblastoid cells transformed and persistently infected with MDV. Virology 213:590-599.
24. Petherbridge, L., A. C. Brown, S. J. Baigent, K. Howes, M. A. Sacco, N. Osterrieder, and V. K. Nair. 2004. Oncogenicity of virulent Marek's disease virus cloned as bacterial artificial chromosomes. J. Virol. 78:13376-13380.
25. Ross, L. J., B. Milne, and P. M. Biggs. 1983. Restriction endonuclease analysis of Marek's disease virus DNA and homology between strains. J. Gen. Virol. 64:2785-2790.
26. Ross, N., M. M. Binns, M. Sanderson, and K. A. Schat. 1993. Alterations in DNA sequence and RNA transcription of the BamHI-H fragment accompany attenuation of oncogenic Marek's disease herpesvirus. Virus Genes 7:33-51.
27. Sambrook, J., and D. W. Russell (ed.). 2001. Plasmids and their usefulness in molecular cloning, p. 1.1-1.162. In Molecular cloning: a laboratory manual, 3rd ed., vol. 1. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
28. Schat, K. A., A. Buckmaster, and L. J. Ross. 1989. Partial transcription map of Marek's disease herpesvirus in lytically infected cells and lymphoblastoid cell lines. Int. J. Cancer 44:101-109.
29. Schat, K. A., B. W. Calnek, and J. Fabricant. 1982. Characterization of two highly oncogenic strains of Marek's disease virus. Avian Pathol. 11:593-605.
30. Schat, K. A., B. W. Calnek, J. Fabricant, and D. L. Graham. 1985. Pathogenesis of infection with attenuated Marek's disease virus strains. Avian Pathol. 14:127-146.
31. Schat, K. A., B. J. Hooft van Iddekinge, H. Boerrigter, P. H. O'Connell, and G. Koch. 1998. Open reading frame L1 of Marek's disease herpesvirus is not essential for in vitro and in vivo virus replication and establishment of latency. J. Gen. Virol. 79:841-849.
32. Schat, K. A., and H. G. Purchase. 1998. Cell-culture methods, p. 223-234. In D. E. Swayne, J. R. Glisson, M. W. Jackwood, J. E. Pearson, and W. M. Reed (ed.), A laboratory manual for the isolation and identification of avian pathogens, 4th ed. American Association of Avian Pathologists, Kennett Square, Pa.
33. Schumacber, D., B. K. Tischer, W. Fuchs, and N. Osterrieder. 2000. Reconstitution of Marek's disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant. J. Virol. 74:11088-11098.
34. Silva, R. F., S. M. Reddy, and B. Lupiani. 2004. Expansion of a unique region in the Marek's disease virus genome occurs concomitantly with attenuation but is not sufficient to cause attenuation. J. Virol. 78:733-740.
35. Tischer, B. K., D. Schumacher, D. Chabanne-Vautherot, V. Zelnik, J. F. Vautherot, and N. Osterrieder. 2005. High-level expression of Marek's disease virus glycoprotein C is detrimental to virus growth in vitro. J. Virol. 79:5889-5899.
36. Tulman, E. R., C. L. Afonso, Z. Lu, L. Zsak, D. L. Rock, and G. F. Kutish. 2000. The genome of a very virulent Marek's disease virus. J. Virol. 74:7980-7988.
37. von Bülow, V., and P. M. Biggs. 1975. Differentiation between strains of Marek's disease virus and turkey herpesvirus by immunofluorescence assays. Avian Pathol. 4:133-146.
38. Weinstock, D., and K. A. Schat. 1987. Virus specific syngeneic killing of reticuloendotheliosis virus transformed cell line target cells by spleen cells. Prog. Clin. Biol. Res. 238:253-263.
39. Wilson, M. R., R. A. Southwick, J. T. Pulaski, V. L. Tieber, Y. Hong, and P. M. Coussens. 1994. Molecular analysis of the glycoprotein C-negative phenotype of attenuated Marek's disease virus. Virology 199:393-402.
40. Witter, R. L. 1972. Epidemiology of Marek's disease: a review, p. 111-122. In P. M. Biggs, G. de The, and L. N. Payne (ed.), Oncogenesis and herpesviruses. IARC, Lyon, France.
41. Witter, R. L. 2001. Protective efficacy of Marek's disease vaccines. Curr. Top. Microbiol. Immunol. 255:57-90.
42. Witter, R. L., and L. Offenbecker. 1979. Nonprotective and temperature-sensitive variants of Marek's disease vaccine viruses. JNCI 62:143-151.
43. Xing, Z., and K. A. Schat. 2000. Expression of cytokine genes in Marek's disease virus-infected chickens and chicken embryo fibroblast cultures. Immunology 100:70-76.
44. Yamaguchi, T., S. L. Kaplan, P. Wakenell, and K. A. Schat. 2000. Transactivation of latent Marek's disease herpesvirus genes in QT35, a quail fibroblast cell line, by herpesvirus of turkeys. J. Virol. 74:10176-10186.
45. Yunis, R., K. W. Jarosinski, and K. A. Schat. 2004. Association between rate of viral genome replication and virulence of Marek's disease herpesvirus strains. Virology 328:142-150.